JAZZ PHARMACEUTICALS, INC.

• JAZZ PHARMACEUTICALS, INC. $3,160,000 In-house, the client's own filings · 7 filings
• TARPLIN, DOWNS & YOUNG, LLC $560,000 Outside firm · 7 filings
• AVENUE SOLUTIONS $350,000 Outside firm · 7 filings
• TIBER CREEK GROUP $350,000 Outside firm · 7 filings
• THE NICKLES GROUP, LLC $180,000 Outside firm · 5 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 946
  ORPHAN Cures Act
  11 filings
• H.R. 4121
  Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  3 filings
• S. 1862
  ORPHAN Cures Act
  3 filings
• H.R. 1
  One Big Beautiful Bill Act
  2 filings
• H.R. 1968
  Full-Year Continuing Appropriations and Extensions Act, 2025
  2 filings
• S. 2256
  Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  2 filings
• H. Con. Res. 14
  Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
  1 filing
• H.R. 8646
  Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
  1 filing
• S. 3019
  No Big Blockbuster Bailouts Act
  1 filing
• S. 891
  Bipartisan Health Care Act
  1 filing

• 2026 $2,200,000 15 filings
• 2025 $2,400,000 18 filings

• Health Issues 22
• Medicare/Medicaid 9
• Budget/Appropriations 7
• Medical/Disease Research/Clinical Labs 7
• Pharmacy 7
• Trade (domestic/foreign) 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 29
• SENATE 29
• Food & Drug Administration (FDA) 6
• Office of Management & Budget (OMB) 5
• Centers For Medicare and Medicaid Services (CMS) 4
• Executive Office of the President (EOP) 4
• U.S. Trade Representative (USTR) 2
• Treasury, Dept of 1
• White House Office 1

• JAZZ PHARMACEUTICALS, PLC Ireland named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.